Literature DB >> 30554937

The optimal combined anteversion pattern to achieve a favorable impingement-free angle in total hip arthroplasty.

Takaaki Ohmori1, Tamon Kabata2, Yoshitomo Kajino1, Daisuke Inoue1, Tadashi Taga1, Takashi Yamamoto1, Tomoharu Takagi1, Junya Yoshitani1, Takuro Ueno1, Ken Ueoka1, Hiroyuki Tsuchiya1.   

Abstract

BACKGROUND: There have been no studies on the differences in impingement-free angle that result from different combined anteversion (CA) patterns. The aim of this study was to find the optimal CA pattern for achieving a favorable impingement-free angle, including bony and prosthetic impingement, in total hip arthroplasty.
METHODS: We evaluated 100 patients with no hip arthritis. We investigated the impingement-free angle (flexion, internal rotation with 90° flexion, extension, and external rotation) after changing the stem and cup anteversions to satisfy several CA patterns [cup anteversion + stem anteversion = 30°, 40°, 50°, and 60°; cup anteversion + 0.7 × stem anteversion = 37.3° (:Widmer's theory); and cup anteversion + 0.77 × stem anteversion = 43.3° (:Yoshimine's theory)] using 3-dimensional templating software.
RESULTS: The impingement-free angle changed dramatically among the various CA patterns. The optimal CA was changed by various stem anteversion. Only CA: Widmer with stem anteversion of 20° satisfied daily-life range of motion (ROM) requirements (flexion ≥130°, internal rotation with 90° flexion ≥ 45°, extension ≥ 40°, external rotation ≥ 40°).
CONCLUSION: Good impingement-free angle cannot be obtained with single fixed CA. Different CA patterns should be used, depending on the differences in the stem anteversion. A CA of 30° with 0° ≤ stem anteversion ≤10°; a CA:Widmer with 20° of stem anteversion; a CA of 40° or Widmer with 30° of stem anteversion. When stem anteversion is ≥40°, CA should be decided by each patient's state. Among them, a stem anteversion of 20° with cup anteversion of 23.3° was found to be the best CA pattern.
Copyright © 2018 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30554937     DOI: 10.1016/j.jos.2018.11.008

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  6 in total

1.  The Direct Anterior Approach Total Hip Arthroplasty Reliably Achieves "Safe Zones" for Combined Anteversion.

Authors:  J Benjamin Jackson; J Ryan Martin; Aric Christal; John L Masonis; Bryan D Springer; J Bohannon Mason
Journal:  Arthroplast Today       Date:  2020-08-22

2.  Validity of the EOS-determined pelvic parameters and orientation with pelvic positional variation: a phantom study.

Authors:  Jung-Taek Kim; Dong Hoon Lee; Han-Dong Lee; Han-Bit Shin; Bumhee Park; Sunghoon Park; Hyung Keun Song
Journal:  Sci Rep       Date:  2021-05-17       Impact factor: 4.379

3.  Measurement of operative femoral anteversion during cementless total hip arthroplasty and influencing factors for using neck-adjustable femoral stem.

Authors:  Jingyang Sun; Bohan Zhang; Lei Geng; Qingyuan Zheng; Juncheng Li; Wenzhe Cao; Ming Ni; Guoqiang Zhang
Journal:  J Orthop Surg Res       Date:  2021-05-31       Impact factor: 2.359

4.  Is Combined Anteversion Equally Affected by Acetabular Cup and Femoral Stem Anteversion?

Authors:  Aidin Eslam Pour; Ran Schwarzkopf; Kunj Pareshkumar Patel; Manan Anjaria; Jean Yves Lazennec; Lawrence D Dorr
Journal:  J Arthroplasty       Date:  2021-02-09       Impact factor: 4.435

5.  No linear correlation between pelvic incidence and acetabular orientation: Retrospective observational study.

Authors:  Jung-Taek Kim; Quan Hu Shen; Chang-Hoon Jeon; Nam-Su Chung; Seungmin Jeong; Han-Dong Lee
Journal:  Medicine (Baltimore)       Date:  2021-04-16       Impact factor: 1.889

6.  Improving Acetabular Component Positioning in Supine Direct Anterior Total Hip Arthroplasty with a Transparency Template: A Novel, Simple, and Cost-effective Technique.

Authors:  Sheng Xu; Jason Beng Teck Lim; Hee Nee Pang
Journal:  Hip Pelvis       Date:  2021-09-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.